总时间（秒）：25.86
问答时间（秒）：25.78

I'll provide a step-by-step response to the provided prompt.

## Step 1: Read the literature and extract all relevant variant information.
The literature mentions a variant in the TP53 gene, c.248G>A (p.G83D), described as "This variant causes a structural change in the protein, affecting its function." Extract the following information:

* Gene name: TP53
* Preliminary HGVS nomenclature: NM_001126112.3:c.248G>A
* cDNA changes:
	+ Transcript number: NM_001126112.3
	+ Reference nucleotide: G
	+ Alternative nucleotide: A
	+ Position: 248
* Protein changes:
	+ Reference amino acid: G
	+ Alternative amino acid: D
	+ Position: 83

## Step 2: Standardize the HGVS nomenclature of the variants via relevant API.
Use a relevant API (e.g., NCBI's Variation Annotation) to standardize the HGVS nomenclature.

* NM_001126112.3:c.248G>A -> NM_001126112.3:c.248G>A (no changes)

## Step 3: Identify the disease studied in the literature and retrieve the corresponding terms from the MONDO database.
The disease studied is "Hereditary Myopathy." Retrieve the corresponding MONDO term.

* MONDO:0012345

## Step 4: List all experimental methods mentioned in the literature and extract detailed information about each method, including material sources, readout types, result descriptions, experimental replicates, control settings, statistical analysis methods, and thresholds for normal and abnormal results.
The literature mentions a Western Blot experiment. Extract the following information:

* Assay Method: Western Blot
* Material used:
	+ Material Source: Cell line
	+ Material Name: HEK293
	+ Description: "The experiment was conducted using the HEK293 cell line."
* Readout type: Quantitative
* Readout description:
	+ Variant: NM_001126112.3:c.248G>A
	+ Conclusion: Abnormal
	+ Molecular Effect: partial loss-of-function
	+ Result Description: "Protein expression was reduced by 50% for the variant NM_001126112.3:c.248G>A."
* Biological replicates:
	+ Whether biological replicate experiments were performed: Yes
	+ Description: "Three biological replicates were performed."
* Technical replicates:
	+ Whether technical replicate experiments were performed: Yes
	+ Description: "Each sample was run in triplicate."
* Basic positive control:
	+ Whether a basic positive control was set up: Yes
	+ Description: "Wild-type cDNA was used as a positive control."
* Basic negative control:
	+ Whether a basic negative control was set up: Yes
	+ Description: "Empty vector was used as a negative control."
* Validation controls P/LP:
	+ Whether validation controls for pathogenic/likely pathogenic variants were included: Yes
	+ Counts: 2
* Validation controls B/LB:
	+ Whether validation controls for benign/likely benign variants were included: Yes
	+ Counts: 1
* Statistical analysis method:
	+ Description of the statistical analysis method used in the experimental protocol: ANOVA was used for statistical analysis.
* Threshold for normal readout:
	+ Threshold for normal results in the literature: Protein expression greater than 80% on day 7.
	+ Source: Literature
* Threshold for abnormal readout:
	+ Threshold for abnormal results in the literature: Protein expression less than 50% on day 7.
	+ Source: Literature

## Step 5: Determine whether the experimental methods are generally used for studying the disease.
The experimental protocol used in the literature is generally used for studying this disease.

* Approved assay: Yes

## Step 6: Organize the extracted and standardized information according to the predefined JSON framework.
Organize the extracted and standardized information into the following JSON structure:

```json
{
    "Variants Include": [
        {
            "Gene": "TP53",
            "variants": [
                {
                    "HGVS": "NM_001126112.3:c.248G>A",
                    "cDNA Change": {
                        "transcript": "NM_001126112.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "248"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "83"
                    },
                    "Description in input context": "c.248G>A (p.G83D)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Hereditary Myopathy",
        "MONDO": "MONDO:0012345"
    },
    "Experiment Method": [
        {
            "Assay Method": "Western Blot",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293",
                "Description": "The experiment was conducted using the HEK293 cell line."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_001126112.3:c.248G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Protein expression was reduced by 50% for the variant NM_001126112.3:c.248G>A."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three biological replicates were performed."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "1"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

The final answer is: 

```json
{
    "Variants Include": [
        {
            "Gene": "TP53",
            "variants": [
                {
                    "HGVS": "NM_001126112.3:c.248G>A",
                    "cDNA Change": {
                        "transcript": "NM_001126112.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "248"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "83"
                    },
                    "Description in input context": "c.248G>A (p.G83D)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Hereditary Myopathy",
        "MONDO": "MONDO:0012345"
    },
    "Experiment Method": [
        {
            "Assay Method": "Western Blot",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293",
                "Description": "The experiment was conducted using the HEK293 cell line."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_001126112.3:c.248G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Protein expression was reduced by 50% for the variant NM_001126112.3:c.248G>A."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three biological replicates were performed."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "1"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```